Company Description
Hamilton Lane Incorporated is a private equity and venture capital firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies.
The firm manages alternative investment strategies like direct credit, direct, fund of fund, evergreen and real assets.
For primary and secondary fund of fund investments, the firm focuses to invest in private equity, buyout, special situations, credit, growth equity, middle market, mature, turnarounds, mezzanine and venture capital funds.
It prefers to invest in energy, industrials, commercial services, internet software & services, consumer discretionary, health care, real estate, information technology, tech-enabled businesses, financials, utilities, and consumer services.
The firm prefers to invest in Africa/Middle East, Asia/Pacific, Europe, Latin America and Caribbean, United States of America, California and surrounding states, Australia, Japan, United Kingdom, and Canada.
The firm prefers to invest between $1 million and $100 million in companies with small- to mid-sized enterprise values.
It prefers to take majority stake. Hamilton Lane Incorporated was founded in 1991 and is based in Conshohocken, Pennsylvania with additional offices across Europe, North America, Asia Pacific and the Middle East.
| Country | United States |
| Founded | 1991 |
| IPO Date | Mar 1, 2017 |
| Industry | Asset Management |
| Sector | Financials |
| Employees | 700 |
| CEO | Erik R. Hirsch |
Contact Details
Address: 110 Washington Street, Suite 1300 Philadelphia, Pennsylvania 19428 United States | |
| Phone | 610 934 2222 |
| Website | hamiltonlane.com |
Stock Details
| Ticker Symbol | HLNE |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001433642 |
| CUSIP Number | 407497106 |
| ISIN Number | US4074971064 |
| Employer ID | 26-2482738 |
| SIC Code | 6282 |
Key Executives
| Name | Position |
|---|---|
| Dr. Juan M. Delgado-Moreira C.F.A., Ph.D. | Co-Chief Executive Officer and Member of the Board |
| Erik R. Hirsch | Co-Chief Executive Officer and Member of the Board |
| Mario Lucio Giannini J.D. | Executive Co-Chairman |
| Andrea F. Kramer | Chief Operating Officer and Chief Risk Officer |
| Jeffrey B. Armbrister | Chief Financial Officer and Treasurer |
| Drew T. Carl CPA | MD and Chief Accounting Officer |
| Lydia A. Gavalis | General Counsel and Secretary |
| Hartley Raymond Rogers | Executive Co-Chairman |
| Andrew Schardt | Vice Chairman, Head of Investment Strategy and Co-Head of Direct Equity |
| Thomas J. Kerr | Co-Head of Investments and Head of Secondary Investments |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 11, 2024 | 8-K | Current Report |
| Oct 7, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Sep 18, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Sep 5, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Sep 5, 2024 | 8-K | Current Report |
| Aug 6, 2024 | 10-Q | Quarterly Report |
| Aug 6, 2024 | 8-K | Current Report |
| Jul 25, 2024 | ARS | Filing |
| Jul 25, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jul 25, 2024 | DEF 14A | Other definitive proxy statements |